Evidence map›Paper›PMID 40146360›Full record

ArticleArchives of dermatological research2025

The effect of rosacea on neurodegenerative and neuropsychiatric diseases: a two-sample Mendelian randomization study.

Xiangjun Hu, Dandan Shen, Hong Cai, Zhangren Yan

Abstract read
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiangjun HuJiangxi University of Chinese Medicine, Nanchang, China.
Dandan ShenThe Affiliated Hospital of Jiangxi University of Chinese Medicine, No.445 Ba-Yi Road, Nanchang, 330006, Jiangxi, China.
Hong CaiJiangxi University of Chinese Medicine, Nanchang, China.
Zhangren YanThe Affiliated Hospital of Jiangxi University of Chinese Medicine, No.445 Ba-Yi Road, Nanchang, 330006, Jiangxi, China. yanzhangren@jxutcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to explore the potential causal relationships between rosacea and Parkinson's disease, Alzheimer's disease, anxiety disorders, and depression with MR analysis. Genetic data for rosacea and the four neurodegenerative and neuropsychiatric disorders were sourced from GWAS databases. After completing stringent quality control procedures, SNPs meeting significance thresholds were selected as IVs. Our primary statistical analysis was conducted by IVW approach. To investigate the robustness of results, heterogeneity tests, sensitivity analyses, and pleiotropy assessments were conducted. Reverse MR analyses were subsequently carried out to further substantiate the causal relationships. The present study discovered a positive correlation between rosacea and an elevated risk of depression (OR = 1.0015, 95% CI = 1.0002-1.0027, P = 0.02). There is no causal evidence to support a connection between rosacea and Parkinson's disease, Alzheimer's disease, or anxiety disorders. Reverse MR analyses indicated no causal associations between these four disorders and the risk of rosacea. The findings reveal that individuals with rosacea may have an elevated risk of depression.

Indexed as

Alzheimer DiseaseAnxiety DisordersDepressionNeurodegenerative DiseasesParkinson DiseaseRosaceaGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMendelian Randomization AnalysisPolymorphism, Single NucleotideDepressionMendelian randomization analysisNeurodegenerative diseaseNeuropsychiatric diseaseRosacea

Identifiers

PMID40146360
PMCPMC11950073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.